Literature DB >> 18452873

Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.

Jonathan N Johnson1, David J Tester, James Perry, Benjamin A Salisbury, Carol R Reed, Michael J Ackerman.   

Abstract

BACKGROUND: The prevalence of atrial fibrillation (AF) in the young (age <50 years) is 0.1%, or 1:1,000 persons. Mutations in KCNQ1-, KCNH2-, and KCNA5-encoded potassium channels and SCN5A-encoded sodium channels have been reported in familial AF. A mechanism of atrial torsade has been suggested to occur in patients with congenital long QT syndrome (LQTS).
OBJECTIVE: The purpose of this study was to determine the prevalence of AF in patients with congenital LQTS.
METHODS: History of documented AF was sought from two independent cohorts. One cohort consisted of 252 consecutive patients (146 females and 106 males, average age at diagnosis 23 +/- 16 years, QTc 465 +/- 51 ms) with genetically proven LQTS seen at Mayo's LQTS Clinic. The second cohort consisted of 205 consecutive patients (133 females and 72 males, average age at testing 23 +/- 16 years, QTc 479 +/- 51 ms) with a positive FAMILION genetic test (PGxHealth) for LQTS.
RESULTS: Early-onset AF was documented in 8 (1.7%) of 457 patients, including 6 (2.4%) of 252 patients seen at Mayo and 2 (1%) of 205 patients with a positive FAMILION test. Five (2.4%) of 211 patients with LQT1-susceptibility mutations had documented AF, compared to 0 of 174 patients with LQT2, 1 of 59 patients with LQT3, 1 of 1 patient with Andersen-Tawil syndrome, and 1 of 34 patients with multiple mutations. The average age at diagnosis of AF of the six patients evaluated at Mayo was 24.3 years (range 4-46 years). Early-onset AF (age <50 years) was significantly more common in patients with LQTS compared to population-based prevalence statistics (P <.001, relative risk 17.5).
CONCLUSION: Compared to the background prevalence of 0.1%, early-onset AF was observed in almost 2% of patients with genetically proven LQTS and should be viewed as an uncommon but possible LQT-related dysrhythmia. Clinical complaints of palpitations warrant thorough assessment in patients with LQTS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452873      PMCID: PMC3940082          DOI: 10.1016/j.hrthm.2008.02.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  22 in total

1.  Cardiac channelopathies: it's in the genes.

Authors:  Michael J Ackerman
Journal:  Nat Med       Date:  2004-05       Impact factor: 53.440

2.  Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndrome.

Authors:  Malek El Yaman; James Perry; Jonathan C Makielski; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2007-10-18       Impact factor: 6.343

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.

Authors:  Timothy M Olson; Alexey E Alekseev; Xiaoke K Liu; Sungjo Park; Leonid V Zingman; Martin Bienengraeber; Srinivasan Sattiraju; Jeffrey D Ballew; Arshad Jahangir; Andre Terzic
Journal:  Hum Mol Genet       Date:  2006-06-13       Impact factor: 6.150

Review 5.  Epidemiology and natural history of atrial fibrillation: clinical implications.

Authors:  S S Chugh; J L Blackshear; W K Shen; S C Hammill; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.

Authors:  Kui Hong; David R Piper; Aurora Diaz-Valdecantos; Josep Brugada; Antonio Oliva; Elena Burashnikov; José Santos-de-Soto; Josefina Grueso-Montero; Ernesto Diaz-Enfante; Pedro Brugada; Frank Sachse; Michael C Sanguinetti; Ramon Brugada
Journal:  Cardiovasc Res       Date:  2005-08-18       Impact factor: 10.787

8.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

9.  Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome.

Authors:  Paulus Kirchhof; Lars Eckardt; Michael R Franz; Gerold Mönnig; Peter Loh; Horst Wedekind; Eric Schulze-Bahr; Günther Breithardt; Wilhelm Haverkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2003-10

10.  Clinical predictors of atrial fibrillation in Brugada syndrome.

Authors:  Mohamad Ali Babai Bigi; Amir Aslani; Shahab Shahrzad
Journal:  Europace       Date:  2007-05-31       Impact factor: 5.214

View more
  58 in total

1.  Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation.

Authors:  Stanley Nattel
Journal:  J Physiol       Date:  2009-04-01       Impact factor: 5.182

2.  "Atrial torsades de pointes" in the long QT syndrome.

Authors:  Stephen P Seslar; Suzanne M Shepard; Charles I Berul
Journal:  J Interv Card Electrophysiol       Date:  2008-11-18       Impact factor: 1.900

3.  Atrial Fibrillation in Long QT Syndrome by Genotype.

Authors:  Pyotr G Platonov; Scott McNitt; Bronislava Polonsky; Spencer Z Rosero; Wojciech Zareba
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-10-15

4.  Selective molecular potassium channel blockade prevents atrial fibrillation.

Authors:  Guy Amit; Kan Kikuchi; Ian D Greener; Lizhu Yang; Victor Novack; J Kevin Donahue
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

5.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

Review 6.  [Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].

Authors:  D Duncker; T König; S Hohmann; C Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-05-22

7.  A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.

Authors:  Azza Ziyadeh-Isleem; Jérôme Clatot; Nathalie Neyroud; Pascale Guicheney; Sabine Duchatelet; Estelle Gandjbakhch; Isabelle Denjoy; Françoise Hidden-Lucet; Stéphane Hatem; Isabelle Deschênes; Alain Coulombe
Journal:  Heart Rhythm       Date:  2014-02-25       Impact factor: 6.343

8.  Atrial Fibrillation and SCN5A Variants.

Authors:  Eleonora Savio-Galimberti; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

9.  Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients.

Authors:  Katerina Pizzuto; Henry L Averns; Adrian Baranchuk; Hoshiar Abdollah; Kevin A Michael; Christopher Simpson; Damian P Redfearn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09-24       Impact factor: 1.468

10.  Atrial fibrillation in cardiac channelopathies.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.